SCHEMBL18749790

SCHEMBL18749790

CCc1cc(C)ccc1OCc1ccccc1CC(=O)NC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGER1 P34995 3/20 0.46
▸ PTGER4 P35408 3/20 0.46
▸ PTGER3 P43115 3/20 0.46
▸ PTGER2 P43116 3/20 0.46
▸ KDM4E B2RXH2 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ LPAR1 Q92633 1/20 0.40
▸ MAPT P10636 3/20 0.39
▸ LMNA P02545 2/20 0.39
▸ SGMS2 Q8NHU3 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ TSHR P16473 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ CASP7 P55210 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18749785 0.88 MRGPRX4 (0.48) L3MBTL1MAPTLMNATDP1TSHR
SCHEMBL18749982 0.88 PTGER1 (0.41) PTGER1PTGER4PTGER3PTGER2KDM4E
SCHEMBL18515245 0.87 POLB (0.41) KDM4EKMT2AMAPTLMNAHTT
SCHEMBL18749812 0.86 MRGPRX4 (0.50) PTGER1PTGER4PTGER3PTGER2KDM4E
SCHEMBL18749696 0.86 MRGPRX4 (0.50) L3MBTL1MAPTHTTNPC1FFAR4
SCHEMBL18749757 0.86 NPC1 (0.51) KDM4EL3MBTL1MEN1KMT2AMAPT
SCHEMBL18749833 0.86 PTGER1 (0.39) PTGER1PTGER4PTGER3PTGER2KDM4E
SCHEMBL18749825 0.86 KDM4E (0.48) PTGER1PTGER4PTGER3PTGER2KDM4E
SCHEMBL7784387 0.86 SMN1; SMN2 (0.51) MEN1KMT2AMAPTLMNAHTT
SCHEMBL18749682 0.85 SLC22A12 (0.42) PTGER1PTGER4PTGER3PTGER2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9907307-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-06 — — US disclosed
US-9788547-B2 Aromatic compound and uses thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-17 — — US disclosed
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170105413-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-0 PTGER1 4793/4885PTGER4 4714/4885PTGER3 4480/4885
US-20170105416-A1 AROMATIC COMPOUND AND USES THEREOF TYR, H1-3, H1-10 PTGER1 3951/4885PTGER4 3553/4885PTGER3 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback